bioAffinity Technologies | D:发行公告
生物亲和力科技 | 8-K:证券购买协议
bioAffinity Technologies | 8-K:bioAffinity Technologies宣布完成250万美元的注册直接发行和并行私募配售
bioAffinity Technologies | 424B5:募资说明书
bioAffinity Technologies | 424B5:募资说明书
bioAffinity Technologies | 8-K:BioAffinity Technologies报告CyPath® Lung销售增长加速
bioAffinity Technologies | 4:持股变动声明-高管 Rebel Vivienne I
bioAffinity Technologies | 4:持股变动声明-高管 Zannes Maria
bioAffinity Technologies | 4:持股变动声明-高管 Zannes Timothy P
bioAffinity Technologies | 4:持股变动声明-高管 Reveles Xavier Trinidad
bioAffinity Technologies | 4:持股变动声明-高管 Dougherty Michael Philip
bioAffinity Technologies | 4:持股变动声明-高管 GIRGENTI STEVEN
bioAffinity Technologies | 8-K:管理层激励奖金计划和高管薪酬
bioAffinity Technologies | 4:持股变动声明-高管 GIRGENTI STEVEN
bioAffinity Technologies | 4:持股变动声明-董事 KNIGHT PETER S
bioAffinity Technologies | 4:持股变动声明-董事 Rubin Gary D
bioAffinity Technologies | 4:持股变动声明-高管 Zannes Maria
bioAffinity Technologies | 4:持股变动声明-董事 DIAMOND STUART
bioAffinity Technologies | 4:持股变动声明-董事 Meghji Mohsin Y
bioAffinity Technologies | 4:持股变动声明-董事 Anderson Robert A.
暂无数据